Home - Products - Metabolic Enzyme/Protease - MAO - (2-Chloropyridin-4-yl)methanamine hydrochloride

(2-Chloropyridin-4-yl)methanamine hydrochloride

CAS No. 916210-98-5

(2-Chloropyridin-4-yl)methanamine hydrochloride( —— )

Catalog No. M20701 CAS No. 916210-98-5

(2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor(IC50 : 126 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
25MG 34 In Stock
50MG 45 In Stock
100MG 63 In Stock
200MG Get Quote In Stock
500MG 148 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (2-Chloropyridin-4-yl)methanamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    (2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor(IC50 : 126 nM).
  • Description
    (2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor(IC50 : 126 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    LOXL2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    916210-98-5
  • Formula Weight
    179.05
  • Molecular Formula
    C6H8Cl2N2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:33 mg/mL (184.31 mM)
  • SMILES
    Cl.NCc1ccnc(Cl)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hutchinson J H Rowbottom M W Lonergan D et al. Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX[J]. ACS Medicinal Chemistry Letters 2017 8(4):423-427.
molnova catalog
related products
  • Osilodrostat

    Osilodrostat (LCI699) is an effective inhibitor of human 11β-hydroxylase (IC50: 2.5 nM) and aldosterone synthase (IC50: 0.7 nM).

  • Pargyline hydrochlor...

    Pargyline hydrochloride is an irreversible inhibitor of monoamine oxidase (MAO) that is used clinically to treat moderate hypertension.

  • A-804598

    A-804598 is a competitive and selective P2X7 receptor antagonist (IC50: 10 nM, rat; 9 nM, mouse; 11 nM, human).